Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.1405 | 0.8042 | 0.7892 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1405 | 0.8042 | 0.5 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0627 | 0.1741 | 0.2452 |
Trypanosoma brucei | hypothetical protein, conserved | 0.05 | 0.0708 | 0.0708 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0627 | 0.1741 | 0.2452 |
Schistosoma mansoni | pyruvate carboxylase | 0.0627 | 0.1741 | 0.1111 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.1646 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1405 | 0.8042 | 0.7892 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.1646 | 1 | 1 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.0627 | 0.1741 | 0.5 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.0627 | 0.1741 | 0.5 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.0627 | 0.1741 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0664 | 0.2044 | 0.1437 |
Chlamydia trachomatis | SWIB complex protein | 0.1405 | 0.8042 | 1 |
Onchocerca volvulus | 0.1405 | 0.8042 | 1 | |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.1405 | 0.8042 | 0.831 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0627 | 0.1741 | 0.1741 |
Trypanosoma brucei | hypothetical protein, conserved | 0.05 | 0.0708 | 0.0708 |
Brugia malayi | brahma associated protein 60 kDa | 0.1405 | 0.8042 | 0.831 |
Schistosoma mansoni | brg-1 associated factor | 0.1405 | 0.8042 | 0.7892 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.0627 | 0.1741 | 0.5 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.1646 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1405 | 0.8042 | 0.7892 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1405 | 0.8042 | 0.7892 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.1646 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.1405 | 0.8042 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.05 | 0.0708 | 0.0708 |
Plasmodium vivax | hypothetical protein, conserved | 0.1405 | 0.8042 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1405 | 0.8042 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.1646 | 1 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.1405 | 0.8042 | 0.831 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1405 | 0.8042 | 0.7892 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.0627 | 0.1741 | 0.5 |
Leishmania major | carboxylase, putative | 0.0627 | 0.1741 | 0.1111 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.1405 | 0.8042 | 0.7892 |
Schistosoma mansoni | hypothetical protein | 0.1405 | 0.8042 | 0.7892 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0627 | 0.1741 | 0.1111 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.1405 | 0.8042 | 0.831 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0627 | 0.1741 | 0.1741 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.1405 | 0.8042 | 0.7892 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.1405 | 0.8042 | 1 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.0627 | 0.1741 | 0.1111 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0627 | 0.1741 | 0.1111 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.0627 | 0.1741 | 0.1111 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.0627 | 0.1741 | 0.5 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.1589 | 0.9533 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1405 | 0.8042 | 1 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.0627 | 0.1741 | 0.5 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.1191 | 0.6314 | 0.7643 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.1589 | 0.9533 | 1 |
Toxoplasma gondii | pyruvate carboxylase | 0.0627 | 0.1741 | 0.1111 |
Brugia malayi | brahma associated protein 60 kDa | 0.1405 | 0.8042 | 0.831 |
Echinococcus multilocularis | tumor protein p63 | 0.0664 | 0.2044 | 0.1437 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.05 | 0.0708 | 0.0708 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.1019 | 0.4918 | 1 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.0627 | 0.1741 | 0.1111 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.0627 | 0.1741 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.1405 | 0.8042 | 0.7892 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.1646 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1405 | 0.8042 | 0.7892 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.1405 | 0.8042 | 0.7892 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 16 uM | Antibacterial activity against Escherichia coli ATCC BAA-198 after 18 to 24 hrs by serial broth microdilution susceptibility test | ChEMBL. | 22230049 |
MIC (functional) | = 33 uM | Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by serial broth microdilution susceptibility test | ChEMBL. | 22230049 |
MIC (functional) | = 33 uM | Antifungal activity against Candida albicans ATCC 90028 after 24 to 48 hrs by serial broth microdilution susceptibility test | ChEMBL. | 22230049 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.